QQQ   432.08 (+0.24%)
AAPL   168.66 (-2.33%)
MSFT   416.77 (+0.76%)
META   502.53 (+0.46%)
GOOGL   154.90 (+0.03%)
AMZN   184.30 (+0.37%)
TSLA   157.42 (-2.51%)
NVDA   872.34 (+1.43%)
AMD   163.88 (+2.22%)
NIO   3.83 (-1.54%)
BABA   69.41 (-1.71%)
T   16.06 (-1.11%)
F   12.12 (-0.90%)
MU   120.89 (-0.40%)
GE   155.12 (+0.92%)
CGC   6.90 (-1.15%)
DIS   114.17 (+1.08%)
AMC   2.74 (+10.93%)
PFE   25.87 (-0.15%)
PYPL   63.94 (+0.68%)
XOM   118.90 (-0.65%)
QQQ   432.08 (+0.24%)
AAPL   168.66 (-2.33%)
MSFT   416.77 (+0.76%)
META   502.53 (+0.46%)
GOOGL   154.90 (+0.03%)
AMZN   184.30 (+0.37%)
TSLA   157.42 (-2.51%)
NVDA   872.34 (+1.43%)
AMD   163.88 (+2.22%)
NIO   3.83 (-1.54%)
BABA   69.41 (-1.71%)
T   16.06 (-1.11%)
F   12.12 (-0.90%)
MU   120.89 (-0.40%)
GE   155.12 (+0.92%)
CGC   6.90 (-1.15%)
DIS   114.17 (+1.08%)
AMC   2.74 (+10.93%)
PFE   25.87 (-0.15%)
PYPL   63.94 (+0.68%)
XOM   118.90 (-0.65%)
QQQ   432.08 (+0.24%)
AAPL   168.66 (-2.33%)
MSFT   416.77 (+0.76%)
META   502.53 (+0.46%)
GOOGL   154.90 (+0.03%)
AMZN   184.30 (+0.37%)
TSLA   157.42 (-2.51%)
NVDA   872.34 (+1.43%)
AMD   163.88 (+2.22%)
NIO   3.83 (-1.54%)
BABA   69.41 (-1.71%)
T   16.06 (-1.11%)
F   12.12 (-0.90%)
MU   120.89 (-0.40%)
GE   155.12 (+0.92%)
CGC   6.90 (-1.15%)
DIS   114.17 (+1.08%)
AMC   2.74 (+10.93%)
PFE   25.87 (-0.15%)
PYPL   63.94 (+0.68%)
XOM   118.90 (-0.65%)
QQQ   432.08 (+0.24%)
AAPL   168.66 (-2.33%)
MSFT   416.77 (+0.76%)
META   502.53 (+0.46%)
GOOGL   154.90 (+0.03%)
AMZN   184.30 (+0.37%)
TSLA   157.42 (-2.51%)
NVDA   872.34 (+1.43%)
AMD   163.88 (+2.22%)
NIO   3.83 (-1.54%)
BABA   69.41 (-1.71%)
T   16.06 (-1.11%)
F   12.12 (-0.90%)
MU   120.89 (-0.40%)
GE   155.12 (+0.92%)
CGC   6.90 (-1.15%)
DIS   114.17 (+1.08%)
AMC   2.74 (+10.93%)
PFE   25.87 (-0.15%)
PYPL   63.94 (+0.68%)
XOM   118.90 (-0.65%)

Yumanity Therapeutics (YMTX) Insider Trading & Ownership

$0.34
-0.02 (-5.56%)
(As of 04/15/2024 ET)

Yumanity Therapeutics (NASDAQ:YMTX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
12.45%
Number Of
Insiders Buying
(Last 3 Years)
0
Number Of
Insiders Selling
(Last 3 Years)
5
Amount Of
Insider Selling
(Last 3 Years)
$73,329.08
Get YMTX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Yumanity Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

YMTX Insider Buying and Selling by Quarter

Yumanity Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/2/2022Michael D WyzgaInsiderSell3,116$1.69$5,266.04  
12/2/2022Richard PetersCEOSell10,890$1.69$18,404.10  
7/5/2022Richard PetersCEOSell4,584$1.85$8,480.40  
6/3/2022Devin Whittemore SmithSVPSell2,923$1.19$3,478.37  
6/3/2022Marie EpsteinInsiderSell1,806$1.19$2,149.14  
6/3/2022Richard PetersCEOSell10,206$1.19$12,145.14  
3/28/2022Richard PetersCEOSell10,715$1.85$19,822.75  
2/3/2022Paulash MohsenInsiderSell1,958$1.83$3,583.14  
(Data available from 1/1/2013 forward)

YMTX Insider Trading Activity - Frequently Asked Questions

Who is on Yumanity Therapeutics's Insider Roster?

The list of insiders at Yumanity Therapeutics includes Devin Whittemore Smith, Marie Epstein, Michael D Wyzga, Paulash Mohsen, and Richard Peters. Learn more on insiders at YMTX.

What percentage of Yumanity Therapeutics stock is owned by insiders?

12.45% of Yumanity Therapeutics stock is owned by insiders. Learn more on YMTX's insider holdings.

Which Yumanity Therapeutics insiders have been selling company stock?

The following insiders have sold YMTX shares in the last 24 months: Devin Whittemore Smith ($3,478.37), Marie Epstein ($2,149.14), Michael D Wyzga ($5,266.04), and Richard Peters ($39,029.64).

How much insider selling is happening at Yumanity Therapeutics?

Insiders have sold a total of 33,525 Yumanity Therapeutics shares in the last 24 months for a total of $49,923.19 sold.


More Insider Trading Tools from MarketBeat

This page (NASDAQ:YMTX) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners